CCR8 and Hepatic fibrosis: Additionally, use of CCR1-, CCR2-, CCR5-, and CCR8-deficient mice or pharmacological inhibition of these axes reduced hepatic macrophage infiltration, hepatic fibrosis, and hepatocellular damage in experimental models of chronic liver injury (28–32).